Literature DB >> 9475074

In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops.

M Malhotra1, D K Majumdar.   

Abstract

In vitro transcorneal permeation of ketorolac tromethamine from 0.5% w/v solutions containing equimolar (0.02 M) concentrations of citrate (pH 6.5), phosphate (pH 6.5 and 7), citrate-phosphate (pH 7) and borate (pH 7) buffers was studied using goat cornea. Cumulative % permeation was maximum with phosphate buffered drops of pH 6.5. The effect of pH and ionic strength on permeation of ketorolac tromethamine from buffered (phosphate) drops was next investigated. Cumulative % permeation of ketorolac tromethamine from buffered drops was pH dependent being maximum at pH 4.5. Adjustment of ionic strength of drops to 0.2 resulted in decreased permeation of drug. Permeation of ketorolac tromethamine from unbuffered drops of varying pH and ionic strength 0.2 was also pH dependent and was maximum at pH 4.5. Buffered drops of pH between 4.5-5.5, ionic strength 0.2, provided better permeation of drug compared to unbuffered drops of same pH and ionic strength. Above pH 6.5 unbuffered drops showed better permeation than buffered drops. Increase in molarity of phosphate buffer (pH 4.5) used in making drops, between 0 to 0.15 M increased permeation. Aqueous drops of ketorolac tromethamine formulated in 0.15 M phosphate buffer of pH 4.5 and ionic strength 0.2 showed maximum cumulative % permeation in vitro. Considering lacrimation induced drug loss in vivo, by buffer of high concentration, ketorolac tromethamine drops formulated in buffer of low molarity, pH 4.5 and ionic strength 0.2 appear suitable.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9475074

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  14 in total

1.  Effect of pH and formulation variables on in vitro transcorneal permeability of flurbiprofen: a technical note.

Authors:  Sajeev Chandran; Archna Roy; Ranendra N Saha
Journal:  AAPS PharmSciTech       Date:  2008-09-16       Impact factor: 3.246

2.  A novel approach to formulation factor of aceclofenac eye drops efficiency evaluation based on physicochemical characteristics of in vitro and in vivo permeation.

Authors:  Vivek Dave; Sarvesh Paliwal
Journal:  Saudi Pharm J       Date:  2013-03-30       Impact factor: 4.330

3.  Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops.

Authors:  Mahendra Singh Rathore; Dipak K Majumdar
Journal:  AAPS PharmSciTech       Date:  2006-07-07       Impact factor: 3.246

4.  Ciprofloxacin as ocular liposomal hydrogel.

Authors:  Khaled Mohamed Hosny
Journal:  AAPS PharmSciTech       Date:  2010-02-12       Impact factor: 3.246

5.  Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.

Authors:  Pravin Kondiba Pawar; Dipak K Majumdar
Journal:  AAPS PharmSciTech       Date:  2006-02-10       Impact factor: 3.246

Review 6.  Cataract surgery and nonsteroidal antiinflammatory drugs.

Authors:  Richard S Hoffman; Rosa Braga-Mele; Kendall Donaldson; Geoffrey Emerick; Bonnie Henderson; Malik Kahook; Nick Mamalis; Kevin M Miller; Tony Realini; Neal H Shorstein; Richard K Stiverson; Barbara Wirostko
Journal:  J Cataract Refract Surg       Date:  2016-09       Impact factor: 3.351

7.  Preparation and evaluation of thermosensitive liposomal hydrogel for enhanced transcorneal permeation of ofloxacin.

Authors:  Khaled Mohamed Hosny
Journal:  AAPS PharmSciTech       Date:  2009-11-10       Impact factor: 3.246

8.  Evidence of carrier mediated transport of ascorbic acid through mammalian cornea.

Authors:  Shivali Singla; D K Majumdar; Sachin Goyal; Gurudas Khilnani
Journal:  Saudi Pharm J       Date:  2011-03-31       Impact factor: 4.330

Review 9.  Topical ocular delivery of NSAIDs.

Authors:  Munish Ahuja; Avinash S Dhake; Surendra K Sharma; Dipak K Majumdar
Journal:  AAPS J       Date:  2008-04-25       Impact factor: 4.009

10.  Transcorneal permeation of ciprofloxacin and diclofenac from marketed eye drops.

Authors:  N Patidar; M S Rathore; D K Sharma; A Middha; V B Gupta
Journal:  Indian J Pharm Sci       Date:  2008-09       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.